Skip to content
Clinical Trials – home
Moleculin Biotech Inc.
Sponsor

Moleculin Biotech Inc.

United States 5300 Memorial Drive Ste 950, 77007-8274, United States

About the sponsor

Moleculin Biotech Inc. focuses its clinical research on acute myeloid leukemia, with studies in adults who have refractory or relapsed AML and in patients receiving first-line therapy.

  • Remission induction
  • Relapsed leukemia
  • Refractory disease

The sponsor’s research activity centers on treatment settings where disease control remains difficult, especially in adult hematologic malignancy care.

About Specializations

Moleculin Biotech Inc. runs clinical trials in conditions such as Acute myeloid leukaemia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Annamycin
  • Sponsor:Moleculin Biotech Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Annamycin
  • Sponsor:Moleculin Biotech Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.